Results 231 to 240 of about 1,882,229 (349)

Antibodies to Epstein-Barr virus in patients with cryptococcosis [PDF]

, 1975
Paul H. Levine, Richard D. Diamond, JoelI. Reisher   +2 more
openalex   +1 more source

Comprehensive resolution and classification of the Epstein Barr virus transcriptome. [PDF]

Nat Commun
Nguyen TD, Wang J, Lam MT, McFerrin H, O'Grady TM, Roberts C, Van Otterloo N, Nguyen TT, Baddoo M, Wyczechowska D, Morales M, Dong Y, Flemington EK.   +12 more
europepmc   +1 more source

The Capacity of Lymphoblastoid Cells to Activate the Alternative Complement Pathway Is Correlated with their Transformation by Epstein-Barr Virus [PDF]

, 1978
I. McConnell, P. J. Lachmann, Thomas F. Lint, George Klein   +3 more
openalex   +1 more source

A guide to heat shock factors as multifunctional transcriptional regulators

The FEBS Journal, EarlyView.
The heat shock factors (HSFs) are evolutionarily conserved transcription factors best known as regulators of molecular chaperone genes in response to heat shock and other protein‐damaging stresses. Vertebrate HSFs, HSF1‐5, HSFX, and HSFY, are implicated in various physiological and pathological processes, including organismal development and cancer ...
Hendrik S. E. Hästbacka, Alejandro J. Da Silva, Lea Sistonen, Eva Henriksson   +3 more
wiley   +1 more source

Atraumatic Splenic Rupture Associated With Epstein-Barr Virus: A Case Report. [PDF]

Cureus
Gamón Briseño DA, Luna Sada AL, Flores Olmos NL, Delgado Duarte R, Ortega Valerio VM.   +4 more
europepmc   +1 more source

Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies

Trends in Molecular Medicine, 2019
A. Bar-Or, M. Pender, R. Khanna, L. Steinman, H. Hartung, T. Maniar, E. Croze, B. Aftab, G. Giovannoni, M. Joshi   +9 more
semanticscholar   +1 more source

Spontaneous Interferon Production and Epstein-Barr Virus Antigen Expression in Human Lymphoid Cell Lines

, 1975
Alexandra Adams, B Lidin, Hans Strander, Kari Cantell   +3 more
openalex   +1 more source

Infection with Epstein-Barr virus. [PDF]

, 1978
D A Warrell, J O Tobin, A. H. Tomlinson
openalex   +1 more source

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow, Robert S. Croop, Alexandra Thiry, Richard B. Lipton   +3 more
wiley   +1 more source

Differential Expression of Epstein-Barr Virus Sequences in Various Breast Cancer Subtypes. [PDF]

Genes (Basel)
Blanchard A, Elmalih N, Muganda P.
europepmc   +1 more source